BIT

5.00%

1.9¢ biotron limited

Ann: BIT225-012 PHASE 2 COVID-19 CLINICAL TRIAL, page-116

First 116 Last

Share
Profile

Follow
caspex

858 Posts.

74

08/09/24

14:39

Post #: 75580995
Share

Originally posted by ozscott81: ↑

The three key themes summarised by the company for the last 12+ months

1.The data from all three Phase 2 trials will be central to demonstrating to potential pharmaceutical partners and regulatory authorities the safety and efficacy of BIT225 in patients with currently unmet medical needs.
2.As with all its programs, the Company is dedicated to generating high value data to de-risk the portfolio ahead of licensing to a major pharmaceutical company for late-stage development, marketing and sales.
3.We appreciate the ongoing support and patience of shareholders while we work to achieve the long-awaitedcommercial outcomes.

So current state of play – We now have three Phase 2 data available. Great! No more waiting on data.
Now we have all central data (good, bad or indifferent) - Question is what is happening now?

Are we still having conversations with pharma to achieve long-awaited commercial outcomes??

Expand

Agreed that there a need for consolidation and clean the decks exercise.
Suspect that the BIT225 Covid announcement is a necessity to help the clean up.
Question is why it took so long and why it did not follow the script as written?

BIT Price at posting: 1.7¢ Sentiment: Hold Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

TIG

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

RAG

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

A3D

Defence MOU for propulsion systems pushes Aurora Lab shares higher

CXU

Cauldron Energy reports "excellent" uranium assays in latest drill run

SHN

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

IMA

Issues emerging as Australian companies tackle critical minerals challenge

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

NWH

NRW Holdings inks $109M deal with BHP for works at Jimblebar

There are more pages in this discussion • 5 more messages in this thread...

First 116 Last

Add BIT (ASX) to my watchlist

(20min delay)
Last 1.9¢		Change -0.001(5.00%)		Mkt cap ! $17.14M

Open	High	Low	Value	Volume
1.9¢	1.9¢	1.9¢	$820	43.17K

Buyers (Bids)

No.	Vol.	Price($)
12	1845030	1.9¢

Sellers (Offers)

Price($)	Vol.	No.
2.0¢	41100	1

View Market Depth

No.	Vol.	Price($)
12	1845030	0.019
9	1690748	0.018
9	2358408	0.017
12	1659350	0.016
6	765000	0.015

Price($)	Vol.	No.
0.020	41100	1
0.021	647442	4
0.022	1107935	5
0.023	1100772	2
0.024	112849	1

Last trade - 14.27pm 11/10/2024 (20 minute delay)

BIT (ASX) Chart

Ann: BIT225-012 PHASE 2 COVID-19 CLINICAL TRIAL, page-116

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Defence MOU for propulsion systems pushes Aurora Lab shares higher

Cauldron Energy reports "excellent" uranium assays in latest drill run

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Issues emerging as Australian companies tackle critical minerals challenge

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: BIT225-012 PHASE 2 COVID-19 CLINICAL TRIAL, page-116

Top Stories

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Defence MOU for propulsion systems pushes Aurora Lab shares higher

Cauldron Energy reports "excellent" uranium assays in latest drill run

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Issues emerging as Australian companies tackle critical minerals challenge

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News